Jennifer Lyn Herron

Insider Reports History

Location
Cambridge, MA
Signature
/s/ Susan M. Kanaya, as Attorney-in-Fact
All insider transactions
Transactions in reports broken out by “transaction date” reported in original SEC filing, see here for transactions aggregated across transaction date

Holdings reported by Jennifer Lyn Herron:

Company Role Class Num Shares Value Price $ Report Date Ownership
GENOCEA BIOSCIENCES, INC. Director Stock Option (Right to Buy) 30,000 09 Sep 2021 Direct
ChemoCentryx, Inc. Director Common Stock 0 $50.95 20 Oct 2022 Direct

Insider Reports Filed by Jennifer Lyn Herron

Symbol Company Period Transactions Value $ Form Type Role Filing Time
/report/000089924322034087-herron-jennifer-lyn-2022-10-20 ChemoCentryx, Inc. 20 Oct 2022 1 $0 4 Director 24 Oct 2022, 19:10
/report/000120919122039982-herron-jennifer-lyn-2022-06-28 ChemoCentryx, Inc. 28 Jun 2022 1 $0 4 Director 30 Jun 2022, 20:27
/report/000120919122039979-herron-jennifer-lyn-2022-06-28 ChemoCentryx, Inc. 28 Jun 2022 0 $0 3 Director 30 Jun 2022, 20:22
/report/000145761221000098-herron-jennifer-lyn-2021-09-09 GENOCEA BIOSCIENCES, INC. 09 Sep 2021 1 $0 4 Director 28 Sep 2021, 16:02
/report/000145761221000097-herron-jennifer-lyn-2021-09-08 GENOCEA BIOSCIENCES, INC. 08 Sep 2021 0 $0 3 Director 28 Sep 2021, 16:00